Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Use of a New Biomarker, HE4, in Combination With Simple Ultrasound Rules in the Prediction of Malignancy in a Pelvic Mass Detected on Ultrasound

NCT03982914 is registered in ClinicalTrials.gov with The University of Hong Kong as lead sponsor.

NCT NCT03982914
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03982914 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Use of a New Biomarker, HE4, in Combination With Simple Ultrasound Rules in the Prediction of Malignancy in a Pelvic Mass Detected on Ultrasound
Lead sponsor
The University of Hong Kong
Phase
Observational
Overall status
Unknown status
Start date
April 1, 2018
Completion date
August 31, 2021
Enrollment
814 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

pelvic mass